Policy and Medicine Archive for January, 2019

Click a link below to view the mailing archive as if it had been sent to you.

2019-01-31 12:30		CMS Names New Senior Medical Advisor for Innovation
2019-01-30 12:30		Reducing Drug Prices at the Top of Legislative Priority Lists
2019-01-29 12:30		White House Council of Economic Advisors Acknowledges Declining Medicine Prices and more...
2019-01-28 12:30		FDA Releases Two Draft Guidances on REMS Programs and more...
2019-01-25 12:30		Azar Touts Administration’s Efforts to Lower Drug Costs
2019-01-24 12:30		CMMI Announces Plans to Expand Medicare Advantage Model and more...
2019-01-23 12:30		IFPMA New Code of Practice Embraced by Biopharmaceutical R&D Industry
2019-01-22 12:30		ABMS Independent Commission Issues Report on MOC Process
2019-01-21 12:30		Bipartisan Concern Simmers Over Transparency at CMMI
2019-01-18 12:30		CDER Priorities for 2019
2019-01-17 12:30		The Trump Administration Has Had an Active Few Weeks in the Drug Pricing Arena
2019-01-16 12:30		FDA Considers 2018 Banner Year for Drug Development
2019-01-15 12:30		Merck Case Makes it to SCOTUS, Focuses on Who Has Final Say in Warning Labels
2019-01-14 12:30		CMS Publishes Additional Guidance on Hospital Transparency Requirements
2019-01-11 12:30		AdvaMed Approves Updated Code of Ethics
2019-01-10 12:30		Philly Gift Ban Stalled…Though Perhaps Only Temporarily
2019-01-09 12:30		California Regulates Pharmacy Benefit Managers
2019-01-08 12:30		Baselga Lands on His Feet Less than Six Months After His Fall
2019-01-07 12:30		CDRH Proposed 510(k) Program Expansion Yields Mixed Reactions
2019-01-04 12:30		PhRMA Submits Comments on CMS Proposed Regulation to Require Drug Pricing Transparency
2019-01-03 12:30		MACPAC Considering Recommending Best Price Safe Harbors at December Public Meeting
2019-01-02 12:30		New Laws to be Implemented Regarding Kickbacks and Opioid Treatment

<< Archive Index • Subscribe >>